Alithea Biotechnology GmbH
- CMO, CRO
- Diagnostics
Alithea empowers biopharma with the world’s most advanced HLA-peptide data platform to accelerate neoantigen discovery, validation, and safety profiling. Our end-to-end solution transforms patient samples into actionable insights using proprietary mass spectrometry, AI, and Big Data. By bridging cutting-edge science with scalable technology, we enable the development of highly personalized and effective cancer therapies—faster and safer. Alithea makes precision oncology a reality.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}